Tyra Biosciences wants to bank $100M for an IPO

Just a few short months after getting off a $106 million funding round and beefing up its C-suite as it looks to tap its SNAP platform to fight resistance to cancer drugs, Tyra Biosciences has filed to raise $100 million in an IPO.